Bill Boyle

Cooley advised Baya Systems, a leader in system intellectual property technology that empowers the acceleration of intelligent compute, on its $36 million Series B.

Cooley advised Snap, a technology company, on its $750 million convertible senior notes offering due 2030, which includes the option for initial purchasers to purchase an additional $100 million aggregate principal amount of notes.

Cooley advised Ethos, an insurtech company that’s transforming the life insurance space, on its $100 million investment from SoftBank Vision Fund 2, which brings its valuation to $2.7 billion. Partner Seth Gottlieb led the Cooley team advising Ethos.

Cooley advised Lyell Immunopharma, a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, on its $425 million initial public offering of 25,000,000 shares of its common stock. Partners Dave Peinsipp, Charlie Kim, Chad Mills and Lauren Creel led the Cooley team advising Lyell on its public debut, which marks the third largest biotech IPO in history.

Cooley advised Ethos, an insurtech company that’s transforming the life insurance space, on its $200 million Series D financing round, which brings its valuation to more than $2 billion. Lawyers Seth Gottlieb, Matthew Bartus and Emily Iannarelli led the team advising Ethos.